It is a chemicals public limited company based in Dharmapuri, Tamil Nadu, India, established in 2008.
2008 | Dharmapuri, Tamil Nadu, India | ActiveSupradent Drugs Limited, a active public limited company, was established on 23 June 2008 in Dharmapuri, Tamil Nadu, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230TZ2008PLC017228. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.07 M.
It upholds a active non-compliant status. Its leadership includes Venkatesan Goppi (Managing Director), Radhakrishnan Venu Murali (Director), Nallakannu Baskara Prabakar (Director). Past directors included Mohamed Sakul Hamid, Radhakrishnan Venu Murali. It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 29 September 2012, with the balance sheet filed on 31 March 2012. It is based at 15/3 South Narasimachary Street, Dharmapuri, Tamil Nadu, 636701.
U24230TZ2008PLC017228
017228
23 June 2008
₹2.50 M
₹1.07 M
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Supradent Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkatesan Goppi | Managing Director | 23 Jun 2008 | Current |
| Radhakrishnan Venu Murali | Director | 01 Jun 2009 | Current |
| Nallakannu Baskara Prabakar | Director | 23 Jun 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Jul 2011 | Past |
| Pramod Abcsdd | Director | 03 Aug 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Supradent Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Supradent Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2011 | Indian Bank | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Supradent Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Supradent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supradent Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Supradent Drugs Limited last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records. was documented.
Supradent Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Coimbatore. was recorded as a recent event.
Progress on A charge with Indian Bank amounted to Rs. 3.00 M with Charge ID 10317206 was registered on 14 Oct 2011. was documented.
Progress on Radhakrishnan Venu Murali was appointed as a Director was appointed as a Director on 01 Jun 2009 & has been associated with this company since 16 years 6 months . was documented.
Venkatesan Goppi was appointed as a Managing Director was appointed as a Managing Director on 23 Jun 2008 & has been associated with this company since 17 years 5 months . was recorded as a recent event.
The activity Nallakannu Baskara Prabakar was appointed as a Director was appointed as a Director on 23 Jun 2008 & has been associated with this company since 17 years 5 months . was completed.
The CIN of Supradent Drugs Limited is U24230TZ2008PLC017228.
Supradent Drugs Limited is headquartered at 15/3 South Narasimachary Street, Dharmapuri, Tamil Nadu, 636701.
Supradent Drugs Limited was incorporated on 23 June 2008.
The current directors of Supradent Drugs Limited are
The primary industry of Supradent Drugs Limited is Chemicals.
Supradent Drugs Limited is unlisted.
The authorized capital of Supradent Drugs Limited is ₹2.50 M, and the paid-up capital is ₹1.07 M.
The compliance status of Supradent Drugs Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX